HHMI
DXCM icon

Howard Hughes Medical Institute’s DexCom DXCM Stock Holding History

Howard Hughes Medical Institute’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-84
Closed -$5.58K – 171
2025
Q4 		$5.58K Hold
84
– – ﹤0.01% 317
2025
Q3 		$5.65K Hold
84
– – ﹤0.01% 312
2025
Q2 		$7.33K Buy
+84
New +$6.58K ﹤0.01% 256
2016
Q3 		– Sell
-2,952
Closed -$59K – 157
2016
Q2 		$59K Buy
+2,952
New +$50.3K 0.02% 146

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Howard Hughes Medical Institute's DXCM Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of DexCom (DXCM) in Q1 2026, closing a stake of 84 shares — an estimated $5.58K sold.

Howard Hughes Medical Institute first reported a position in DXCM in Q2 2016 and held it in 4 quarters. The position peaked at $59K in Q2 2016. 960 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Howard Hughes Medical Institute reported no remaining DexCom position as of Q1 2026 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 84 DexCom shares in Q1 2026, an estimated $5.58K.
  • Howard Hughes Medical Institute first reported a position in DexCom in Q2 2016 and held it in 4 quarters.
  • Howard Hughes Medical Institute's DexCom position peaked at $59K in Q2 2016.
  • 960 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.